Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study. J Thromb Haemost. 2019 11; 17(11):1866-1874.
View in:
PubMed
subject areas
Aged
Aged
Blood Coagulation
Blood Coagulation
Dalteparin
Dalteparin
Drug Administration Schedule
Drug Administration Schedule
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Incidence
Incidence
Male
Male
Middle Aged
Middle Aged
Neoplasms
Neoplasms
Prospective Studies
Prospective Studies
Pulmonary Embolism
Pulmonary Embolism
Pyridines
Pyridines
Recurrence
Recurrence
Risk Factors
Risk Factors
Thiazoles
Thiazoles
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Venous Thrombosis
authors with profiles
Gary E Raskob